About the AlzMatch Study
The AlzMatch Study tests whether a single blood test, collected at community-based laboratories, can help speed clinical trial enrollment by identifying people more likely to experience changes in their brains associated with Alzheimer’s disease.
AlzMatch is helping us find people who are most eligible for Alzheimer’s prevention trials by way of a simple blood draw. AlzMatch is currently invite-only.
Why should I join AlzMatch?
Blood tests are the cutting edge of Alzheimer’s research, and you could be part of it! AlzMatch helps us find people who may be most eligible to participate in Alzheimer’s disease prevention studies.
Am I eligible to join AlzMatch?
You may be eligible if you are:
- A current participant in the Alzheimer Prevention Trials (APT) Webstudy
- Over 50 years of age
- Have no diagnosis of dementia
What happens when I join AlzMatch?
Read & Sign Consent Form
Schedule Blood Draw Online
Visit a Local Quest for Blood Draw
Learn if Eligible to Screen for Research Study
How is the study funded?
The AlzMatch Study is funded by several organizations including:
- National Institutes of Health
- Gates Ventures
- Epstein Family Alzheimer’s Disease Research Collaboration
Who is involved with AlzMatch?
AlzMatch is being conducted in special partnership with the APT Webstudy, including leading Alzheimer’s disease researchers from the following institutions:
